# Suzhou Zelgen Biopharmaceuticals Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/suzhou-zelgen-biopharmaceuticals-co

- Industry: Healthcare Specialists
- Headquarters: Suzhou, China
- Website: www.zelgen.com
- Total disclosed funding: $62M
- Latest round: Series D (Dec 26, 2018)
- Investors on record: 13

## About

Based in Kunshan, China and established in 2009, Suzhou Zelgen Biopharmaceuticals Co., Ltd. is a developer, manufacturer and seller of new medications for the treatments of cancer, hematologic diseases, etc.

## Funding rounds

- Series D, Dec 26, 2018 — DYEE Capital, Yanyuan Shouke Capital, Saifo Capital
- Series B, Jan 15, 2018, $62M — NLVC, Share Capital, Minsheng Life Insurance, Shenzhen Capital Real Estate Fund, China Youth Finance Network
- Series A, Aug 1, 2017 — NLVC, Share Capital, InnoSpring, Yingke Private Equity
- Series A, Aug 29, 2016 — Yingke Private Equity, Shenzhen Guozhong Venture Capital, China Elite Capital, Shenzhen Capital Real Estate Fund
- Angel, Jan 1, 2015 — IPV Capital Partners

## Investors

- IPV Capital Partners (https://capitalatlas.ai/funds/ipv-capital-partners) — Angel
- Yingke Private Equity (https://capitalatlas.ai/funds/yingke-private-equity) — Series A
- Shenzhen Guozhong Venture Capital (https://capitalatlas.ai/funds/shenzhen-guozhong-venture-capital) — Series A
- China Elite Capital — Series A
- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Series A, Series B
- NLVC (https://capitalatlas.ai/funds/nlvc) — Series A, Series B
- Share Capital (https://capitalatlas.ai/funds/share-capital) — Series A, Series B
- InnoSpring (https://capitalatlas.ai/funds/innospring) — Series A
- Minsheng Life Insurance — Series B
- China Youth Finance Network — Series B
- DYEE Capital (https://capitalatlas.ai/funds/dyee-capital) — Series D
- Yanyuan Shouke Capital — Series D
- Saifo Capital — Series D